ANAB Competitors & Alternatives
Compare AnaptysBio Inc with similar stocks in the same industry
Biotechnology
ANAB
Main Stock$53.87
Tradestie Score
46
Market Cap
$894.30M
Revenue Growth
-0.1%
Analyst Upside
+66.4%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$21.24
|
$1.74B | - | 44 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$36.90
|
$1.68B | - | 45 | Compare |
|
MNKD
Mannkind Corporation
|
$3.75
|
$1.65B | - | 37 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$44.40
|
$1.63B | - | 52 | Compare |
|
BHVN
Biohaven Ltd.
|
$12.71
|
$1.57B | - | 48 | Compare |
|
VCEL
Vericel Corporation
|
$38.34
|
$1.56B | 80.6 | 51 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$106.20
|
$1.55B | - | 52 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$41.52
|
$1.55B | 13.5 | 46 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$38.02
|
$1.55B | - | 52 | Compare |
|
NVAX
Novavax Inc
|
$9.42
|
$1.54B | - | 48 | Compare |
More ANAB Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry